EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhanced HDR-mediated correction of heterozygous COL7A1 mutations for recessive dystrophic epidermolysis bullosa

John M T Hunt, Alex du Rand, Daniel Verdon, Leah Clemance, Evert Loef, Chloe Malhi, Ben Buttle, David J H F Knapp, Yale S Michaels, Jonathan Garlick, P Rod Dunbar, Diana Purvis und 2 weitere

Molecular Therapy Nucleic Acids · 2025-03 · 36 (1) · 102472

DOI: 10.1016/j.omtn.2025.102472 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy Nucleic Acids, 2025-03. Verfasst von John M T Hunt und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, The University of Auckland, Auckland 1010, New Zealand. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University of Auckland, Maurice Wilkins Centre for Molecular Biodiscovery, Auckland Medical Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

CRISPR-Cas9MT: RNA/DNA EditingOxford Nanopore Technology sequencingdual-nickaseepidermolysis bullosagene therapyhomology-directed repairskin engineering

Autor:innen und Institutionen

  • School of Biological Sciences, The University of Auckland, Auckland 1010, New Zealand.
  • Maurice Wilkins Center, New Zealand.
  • Institut de recherche en immunologie et en cancérologie (IRIC) and Département de Pathologie et Biologie Cellulaire, Université de Montréal, Montréal, QC H3T 1J4, Canada.
  • Paul Albrechtsen Research Institute CancerCare Manitoba, Winnipeg, MB R2H 2A6, Canada.
  • Department of Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
  • School of Dental Medicine, Tufts University, Boston, MA 02111, USA.

Förderung

  • The University of Auckland
  • Maurice Wilkins Centre for Molecular Biodiscovery
  • Auckland Medical Research Foundation

Zitieren

APA

Hunt, J. M. T., du Rand, A., Verdon, D., Clemance, L., Loef, E., Malhi, C., Buttle, B., Knapp, D. J. H. F., Michaels, Y. S., Garlick, J., Dunbar, P. R., Purvis, D., Feisst, V., & Sheppard, H. (2025). Enhanced HDR-mediated correction of heterozygous COL7A1 mutations for recessive dystrophic epidermolysis bullosa. Molecular Therapy Nucleic Acids, 36(1), 102472. https://doi.org/10.1016/j.omtn.2025.102472

Vancouver

Hunt JMT, du Rand A, Verdon D, Clemance L, Loef E, Malhi C, et al. Enhanced HDR-mediated correction of heterozygous COL7A1 mutations for recessive dystrophic epidermolysis bullosa. Molecular Therapy Nucleic Acids. 2025;36(1):102472. doi:10.1016/j.omtn.2025.102472

BibTeX
@article{Hunt2025,
  author = {Hunt, John M T and du Rand, Alex and Verdon, Daniel and Clemance, Leah and Loef, Evert and Malhi, Chloe and Buttle, Ben and Knapp, David J H F and Michaels, Yale S and Garlick, Jonathan and Dunbar, P Rod and Purvis, Diana and Feisst, Vaughan and Sheppard, Hilary},
  title = {Enhanced HDR-mediated correction of heterozygous COL7A1 mutations for recessive dystrophic epidermolysis bullosa},
  journal = {Molecular Therapy Nucleic Acids},
  year = {2025},
  volume = {36},
  number = {1},
  pages = {102472},
  doi = {10.1016/j.omtn.2025.102472}
}
Kostenlos starten →